Proton Magnetic Resonance Spectroscopy as a Probe into the Pathophysiology of Autism Spectrum Disorders (ASD): A Review

Autism Research

Volumn 6, Issue 2, 2013, Pages 119-133

  Baruth, Joshua M ^a   Wall, Christopher A ^a   Patterson, Marc C ^a   Port, John D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autism Spectrum Disorders; Glutamate; myo inositol; N acetylaspartate; Proton magnetic resonance spectroscopy

Indexed keywords

4 AMINOBUTYRIC ACID; CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

AMYGDALOID NUCLEUS; ARTICLE; AUTISM; CEREBELLUM; CINGULATE GYRUS; DENDRITE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; MACROCEPHALY; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE FIBER; NEUROIMAGING; PARIETAL LOBE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE; THALAMUS; WHITE MATTER;

AUTISM SPECTRUM DISORDERS; GLUTAMATE; MYO-INOSITOL; N-ACETYLASPARTATE; PROTON MAGNETIC RESONANCE SPECTROSCOPY;

ASPARTIC ACID; BRAIN; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHOLINE; CREATINE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 84876786289     PISSN: 19393792     EISSN: 19393806     Source Type: Journal    
DOI: 10.1002/aur.1273     Document Type: Article

References (118)

1. Amaral, D.G., Schumann, C.M., & Nordahl, C.W. (2008). Neuroanatomy of autism. Trends in Neurosciences, 31, 137-145.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (DSM-IV TR), 4th ed. Washington, DC: American Psychiatric Association.
3. Arai, T., Jones, C.R., Rapoport, S.I., & Weiss, S.R. (1996). Evidence for membrane remodeling in ipsilateral thalamus and amygdala following left amygdala-kindled seizures in awake rats. Brain Research, 743, 131-140.
4. Arnold, D.L., Matthews, P.M., Francis, G.S., O'Connor, J., & Antel, J.P. (1992). Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Annals of Neurology, 31, 235-241.
5. Assaf, M., Jagannathan, K., Calhoun, V.D., Miller, L., Stevens, M.C., etal. (2010). Abnormal functional connectivity of default mode sub-networks in autism spectrum disorder patients. NeuroImage, 53, 247-256.
6. Babikian, T., Marion, S.D., Copeland, S., Alger, J.R., O'Neill, J., etal. (2010). Metabolic levels in the corpus callosum and their structural and behavioral correlates after moderate to severe pediatric TBI. Journal of neurotrauma, 27, 473-481.
7. Bailey, A., Luthert, P., Dean, A., Harding, B., Janota, I., etal. (1998). A clinicopathological study of autism. Brain, 121(Pt 5), 889-905.
8. Baron-Cohen, S., Ring, H.A., Wheelwright, S., Bullmore, E.T., Brammer, M.J., etal. (1999). Social intelligence in the normal and autistic brain: An fMRI study. European Journal of Neuroscience, 11, 1891-1898.
9. Bartha, R., Drost, D.J., Menon, R.S., & Williamson, P.C. (2000). Comparison of the quantification precision of human short echo time (1)h spectroscopy at 1.5 and 4.0 tesla. Magnetic Resonance in Medicine, 44, 185-192.
10. Baruth, J.M., Casanova, M., El-Baz, A., Horrell, T., Mathai, G., etal. (2010). Low-frequency repetitive transcranial magnetic stimulation (rTMS) modulates evoked-gamma oscillations in autism spectrum disorder (ASD). Journal of Neurotherapy, 14, 179-194.
11. Bauman, M.L., & Kemper, T.L. (2005). Neuroanatomic observations of the brain in autism: A review and future directions. International Journal of Developmental Neuroscience, 23, 183-187.
12. Belsito, K.M., Law, P.A., Kirk, K.S., Landa, R.J., & Zimmerman, A.W. (2001). Lamotrigine therapy for autistic disorder: A randomized, double-blind, placebo-controlled trial. Journal of autism and developmental disorders, 31, 175-181.
13. Bernardi, S., Anagnostou, E., Shen, J., Kolevzon, A., Buxbaum, J.D., etal. (2011). In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism. Brain Research, 1380, 198-205.
14. Birken, D.L., & Oldendorf, W.H. (1989). N-acetyl-L-aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neuroscience and Biobehavioral Reviews, 13, 23-31.
15. Bluml, S., Seymour, K.J., & Ross, B.D. (1999). Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in in vivo human brain. Magnetic Resonance in Medicine, 42, 643-654.
16. Boddaert, N., & Zilbovicius, M. (2002). Functional neuroimaging and childhood autism. Pediatric Radiology, 32, 1-7.
17. Brand, A., Richter-Landsberg, C., & Leibfritz, D. (1993). Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Developmental Neuroscience, 15, 289-298.
18. Casanova, M.F. (2007). The neuropathology of autism. Brain Pathology, 17, 422-433.
19. Casanova, M.F., Buxhoeveden, D., & Brown, C. (2002a). Clinical and macroscopic correlates of minicolumnar pathology in autism. Journal of Child Neurology, 17, 692-695.
20. Casanova, M.F., Buxhoeveden, D.P., Switala, A.E., & Roy, E. (2002b). Minicolumnar pathology in autism. Neurology, 58, 428-432.
21. Casanova, M.F., van Kooten, I., van Engeland, H., Heinsen, H., Steinbusch, H.W.M., etal. (2006). Minicolumnar abnormalities in autism. Acta Neuropathologica, 112, 287-303.
22. Chakraborty, G., Mekala, P., Yahya, D., Wu, G., & Ledeen, R.W. (2001). Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipd synthesis: Evidence for myelin-associated aspartocyclase. Journal of Neurochemistry, 78, 736-745.
23. Choudhury, P.R., Lahiri, S., & Rajamma, U. (2012). Glutamate mediated signaling in the pathophysiology of autism spectrum disorders. Pharmacology, Biochemistry, and Behavior, 100, 841-849.
24. Chugani, D.C., Sundram, B.S., Behen, M., Lee, M.L., & Moore, G.J. (1999). Evidence of altered energy metabolism in autistic children. Progress in neuro-psychopharmacology & Biological Psychiatry, 23, 635-641.
25. Clark, J.B. (1998). N-acetyl aspartate: A marker for neuronal loss or mitochondrial dysfunction. Developmental Neuroscience, 20, 271-276.
26. Cook, E.H., Jr, Courchesne, R.Y., Cox, N.J., Lord, C., Gonen, D., etal. (1998). Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. American Journal of Human Genetics, 62, 1077-1083.
27. Corrigan, N.M., Shaw, D.W., Richards, T.L., Estes, A.M., Friedman, S.D., etal. (2012). Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder. Journal of Autism and Developmental Disorders, 42, 105-115.
28. Courchesne, E., & Pierce, K. (2005). Brain overgrowth in autism during a critical time in development: Implications for frontal pyramidal neuron and interneuron development and connectivity. International Journal of Developmental Neuroscience, 23, 153-170.
29. Coyle, J., Leski, M., & Morrison, J. (2002). The diverse roles of L-glutamic acid in brain signal transduction Neuropsychopharmacology: The Fifth Generation of Progress. In K. David, D. Charney, J. Coyle, & C. Nemeroff (Eds.), Neuropsychopharmacology - The Fifth Generation of Progress. (pp. 71-90). Philadelphia, PA: Philadelphia Lippincott, Williams, and Wilkins.
30. Critchley, H.D., Daly, E.M., Bullmore, E.T., Williams, S.C., Van Amelsvoort, T., etal. (2000). The functional neuroanatomy of social behaviour: Changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain, 123 (Pt 11): 2203-2212.
31. Daikhin, Y., & Yudkoff, M. (2000). Compartmentation of brain glutamate metabolism in neurons and glia. The Journal of Nutrition, 130(4S Suppl), 1026S-1031S.
32. DeVito, T.J., Drost, D.J., Neufeld, R.W., Rajakumar, N., Pavlosky, W., etal. (2007). Evidence for cortical dysfunction in autism: A proton magnetic resonance spectroscopic imaging study. Biological Psychiatry, 61, 465-473.
33. Endo, T., Shioiri, T., Kitamura, H., Kimura, T., Endo, S., etal. (2007). Altered chemical metabolites in the amygdala-hippocampus region contribute to autistic symptoms of autism spectrum disorders. Biological Psychiatry, 62, 1030-1037.
34. Fatemi, S.H. (2008). The hyperglutamatergic hypothesis of autism. Progress in Neuro-psychopharmacology & Biological Psychiatry, 32, 911, author reply 912-913.
35. Fatemi, S.H., & Folsom, T.D. (2011). Dysregulation of fragile x mental retardation protein and metabotropic glutamate receptor 5 in superior frontal cortex of individuals with autism: A postmortem brain study. Molecular Autism, 2, 6-16.
36. Fatemi, S.H., Folsom, T.D., Reutiman, T.J., & Thuras, P.D. (2009a). Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum, 8, 64-69.
37. Fatemi, S.H., Halt, A.R., Stary, J.M., Kanodia, R., Schulz, S.C., & Realmuto, G.R. (2002). Glutamic acid decarboxylase 65 and 67kDa proteins are reduced in autistic parietal and cerebellar cortices. Biological Psychiatry, 52, 805-810.
38. Fatemi, S.H., Reutiman, T.J., Folsom, T.D., & Thuras, P.D. (2009b). GABA(A) receptor downregulation in brains of subjects with autism. Journal of Autism and Developmental Disorders, 39, 223-230.
39. Fayed, N., & Modrego, P.J. (2005). Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy. Academic Radiology, 12, 566-569.
40. Friedman, S.D., Brooks, W.M., Jung, R.E., Chiulli, S.J., Sloan, J.H., etal. (1999). Quantitative proton MRS predicts outcome after traumatic brain injury. Neurology, 52, 1384-1391.
41. Friedman, S.D., Shaw, D.W., Artru, A.A., Dawson, G., Petropoulos, H., & Dager, S.R. (2006). Gray and white matter brain chemistry in young children with autism. Archives of General Psychiatry, 63, 786-794.
42. Friedman, S.D., Shaw, D.W., Artru, A.A., Richards, T.L., Gardner, J., etal. (2003). Regional brain chemical alterations in young children with autism spectrum disorder. Neurology, 60, 100-107.
43. Fujii, E., Mori, K., Miyazaki, M., Hashimoto, T., Harada, M., & Kagami, S. (2010). Function of the frontal lobe in autistic individuals: A proton magnetic resonance spectroscopic study. Journal of Medical Investigation, 57, 35-44.
44. Fux, M., Levine, J., Aviv, A., & Belmaker, R.H. (1996). Inositol treatment of obsessive-compulsive disorder. The American journal of Psychiatry, 153, 1219-1221.
45. Gabis, L., Wei, H., Azizian, A., DeVincent, C., Tudorica, A., etal. (2008). 1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders. Journal of Child Neurology, 23, 766-774.
46. Gadian, D.G. (1996). NMR and its applications to living systems. New York: Oxford University Press.
47. Gomes, E., Pedroso, F.S., & Wagner, M.B. (2008). Auditory hypersensitivity in the autistic spectrum disorder. Pro-fono, 20, 279-284.
48. Govindaraju, V., Young, K., & Maudsley, A.A. (2000). Proton NMR chemical shifts and coupling constants for brain metabolites. NMR in Biomedicine, 13, 129-153.
49. Gupta, R.K., Cloughesy, T.F., Sinha, U., Garakian, J., Lazareff, J., etal. (2000). Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. Journal of Neuro-oncology, 50, 215-226.
50. Hallmayer, J., Cleveland, S., Torres, A., Phillips, J., Cohen, B., etal. (2011). Genetic heritability and shared environmental factors among twin pairs with autism. Archives of General Psychiatry, 68, 1095-1102.
51. Happe, F., Ehlers, S., Fletcher, P., Frith, U., Johansson, M., etal. (1996). "Theory of mind" in the brain. Evidence from a PET scan study of Asperger syndrome. Neuroreport, 8, 197-201.
52. Harada, M., Taki, M.M., Nose, A., Kubo, H., Mori, K., etal. (2011). Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument. Journal of Autism and Developmental Disorders, 41, 447-454.
53. Hardan, A.Y., Minshew, N.J., Melhem, N.M., Srihari, S., Jo, B., etal. (2008). An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Research, 163, 97-105.
54. Hashimoto, T., Kawano, N., Fukuda, K., Endo, S., Mori, K., etal. (1998). Proton magnetic resonance spectroscopy of the brain in three cases of Rett syndrome: Comparison with autism and normal controls. Acta Neuropathologica Scandinavica, 98, 8-14.
55. Hashimoto, T., Tayama, M., Miyazaki, M., Yoneda, Y., Yoshimoto, T., etal. (1997). Differences in brain metabolites between patients with autism and mental retardation as detected by in vivo localized proton magnetic resonance spectroscopy. Journal of Child Neurology, 12, 91-96.
56. Hazlett, H.C., Poe, M.D., Gerig, G., Smith, R.G., & Piven, J. (2006). Cortical gray and white brain tissue volume in adolescents and adults with autism. Biological Psychiatry, 59, 1-6.
57. Herbert, M.R., Ziegler, D.A., Makris, N., Filipek, P.A., Kemper, T.L., etal. (2004). Localization of white matter volume increase in autism and developmental language disorder. Annals of Neurology, 55, 530-540.
58. Hisaoka, S., Harada, M., Nishitani, H., & Mori, K. (2001). Regional magnetic resonance spectroscopy of the brain in autistic individuals. Neuroradiology, 43, 496-498.
59. Horwitz, B., Rumsey, J.M., Grady, C.L., & Rapoport, S.I. (1988). The cerebral metabolic landscape in autism. Intercorrelations of regional glucose utilization. Archives of Neurology, 45, 749-755.
60. Ipser, J.C., Syal, S., Bentley, J., Adnams, C.M., Steyn, B., & Stein, D.J. (2012). 1H-MRS in autism spectrum disorders: A systematic meta-analysis. Metabolic Brain Disease, 27, 275-287.
61. Jansen, J.F., Backes, W.H., Nicolay, K., & Kooi, M.E. (2006). 1H MR spectroscopy of the brain: Absolute quantification of metabolites. Radiology, 240, 318-332.
62. Kadota, T., Horinouchi, T., & Kuroda, C. (2001). Development and aging of the cerebrum: Assessment with proton MR spectroscopy. American Journal of Neuroradiology, 22, 128-135.
63. Kern, J.K., & Jones, A.M. (2006). Evidence of toxicity, oxidative stress, and neuronal insult in autism. Journal of Toxicology and Environmental Health. Part B, Critical reviews, 9, 485-499.
64. Kleinhans, N.M., Richards, T., Johnson, L.C., Weaver, K.E., Greenson, J., etal. (2011). fMRI evidence of neural abnormalities in the subcortical face processing system in ASD. NeuroImage, 54, 697-704.
65. Kleinhans, N.M., Schweinsburg, B.C., Cohen, D.N., Müller, R.A., & Courchesne, E. (2007). N-acetyl aspartate in autism spectrum disorders: Regional effects and relationship to fMRI activation. Brain Research, 1162, 85-97.
66. van der Knaap, M.S., van der Grond, J., van Rijen, P.C., Faber, J.A., Valk, J., & Willemse, K. (1990). Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology, 176, 509-515.
67. Kreis, R., Ernst, T., & Ross, B.D. (1993). Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magnetic Resonance in Medicine, 30, 424-437.
68. Kreis, R., Wingeier, K., Vermathen, P., Giger, E., Joncourt, F., etal. (2011). Brain metabolite composition in relation to cognitive function and dystrophin mutations in boys with Duchenne muscular dystrophy. NMR in Biomedicine, 24, 253-262.
69. Laurence, J.A., & Fatemi, S.H. (2005). Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum, 4, 206-210.
70. Levine, J., Barak, Y., Gonzalves, M., Szor, H., Elizur, A., etal. (1995). Double-blind, controlled trial of inositol treatment of depression. The American Journal of Psychiatry, 152, 792-794.
71. Levitt, J.G., O'Neill, J., Blanton, R.E., Smalley, S., Fadale, D., etal. (2003). Proton magnetic resonance spectroscopic imaging of the brain in childhood autism. Biological Psychiatry, 54, 1355-1366.
72. Ma, D.Q., Whitehead, P.L., Menold, M.M., Martin, E.R., Ashley-Koch, A.E., etal. (2005). Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. American Journal of Human Genetics, 77, 377-388.
73. MacKay, S., Meyerhoff, D.J., Constans, J.M., Norman, D., Fein, G., & Weiner, M.W. (1996). Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. Archives of Neurology, 53, 167-174.
74. McCaffery, P., & Deutsch, C.K. (2005). Macrocephaly and the control of brain growth in autistic disorders. Progress in Neurobiology, 77, 38-56.
75. McKenna, M.C. (2007). The glutamate-glutamine cycle is not stoichiometric: Fates of glutamate in brain. Journal of Neuroscience Research, 85, 3347-3358.
76. Michaelis, T., Merboldt, K.D., Bruhn, H., Hanicke, W., & Frahm, J. (1993). Absolute concentrations of metabolites in the adult human brain in vivo: Quantification of localized proton MR spectra. Radiology, 187, 219-227.
77. Miller, B.L., Chang, L., Booth, R., Ernst, T., Cornford, M., etal. (1996). In vivo 1H MRS choline: Correlation with in vitro chemistry/histology. Life Sciences, 58, 1929-1935.
78. Mori, K., Hashimoto, T., Harada, M., Yoneda, Y., Shimakawa, S., etal. (2001). [Proton magnetic resonance spectroscopy of the autistic brain]. No To Hattatsu, 33, 329-335.
79. Murias, M., Webb, S.J., Greenson, J., & Dawson, G. (2007). Resting state cortical connectivity reflected in EEG coherence in individuals with autism. Biological Psychiatry, 62, 270-273.
80. Murphy, D.G., Critchley, H.D., Schmitz, N., McAlonan, G., Van Amelsvoort, T., etal. (2002). Asperger syndrome: A proton magnetic resonance spectroscopy study of brain. Archives of General Psychiatry, 59, 885-891.
81. Nelson, K.B., Grether, J.K., Croen, L.A., Dambrosia, J.M., Dickens, B.F., etal. (2001). Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Annals of Neurology, 49, 597-606.
82. Noriuchi, M., Kikuchi, Y., Yoshiura, T., Kira, R., Shigeto, H., etal. (2010). Altered white matter fractional anisotropy and social impairment in children with autism spectrum disorder. Brain Research, 1362, 141-149.
83. O'Brien, F.M., Page, L., O'Gorman, R.L., Bolton, P., Sharma, A., etal. (2010). Maturation of limbic regions in Asperger syndrome: A preliminary study using proton magnetic resonance spectroscopy and structural magnetic resonance imaging. Psychiatry Research, 184, 77-85.
84. Otsuka, H., Harada, M., Mori, K., Hisaoka, S., & Nishitani, H. (1999). Brain metabolites in the hippocampus-amygdala region and cerebellum in autism: An 1H-MR spectroscopy study. Neuroradiology, 41, 517-519.
85. Page, L.A., Daly, E., Schmitz, N., Simmons, A., Toal, F., etal. (2006). In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. The American Journal of Psychiatry, 163, 2189-2192.
86. Palatnik, A., Frolov, K., Fux, M., & Benjamin, J. (2001). Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. Journal of Clinical Psychopharmacology, 21, 335-339.
87. Perich-Alsina, J., Aduna de Paz, M., Valls, A., & Muñoz-Yunta, J.A. (2002). [Thalamic spectroscopy using magnetic resonance in autism]. Revista de Neurologia, 34, S68-S71.
88. Perry, E.K., Lee, M.L., Martin-Ruiz, C.M., Court, J.A., Volsen, S.G., etal. (2001). Cholinergic activity in autism: Abnormalities in the cerebral cortex and basal forebrain. The American Journal of Psychiatry, 158, 1058-1066.
89. Pfefferbaum, A., Adalsteinsson, E., Spielman, D., Sullivan, E.V., & Lim, K.O. (1999). In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging. Magnetic Resonance in Medicine, 41, 276-284.
90. Pfund, Z., Chugani, D.C., Juhasz, C., Muzik, O., Chugani, H.T., etal. (2000). Evidence for coupling between glucose metabolism and glutamate cycling using FDG PET and 1H magnetic resonance spectroscopy in patients with epilepsy. Journal of Cerebral Blood Flow and Metabolism, 20, 871-878.
91. Prost, R.W., Mark, L., Mewissen, N.J., & Li, S.J. (1997). Detection of glutamate/glutamine resonances by 1H magnetic resonance spectroscopy at 0.5 tesla. Magnetic Resonance in Medicine, 37, 615-618.
92. Purcell, A.E., Jeon, O.H., Zimmerman, A.W., Blue, M.E., & Pevsner, J. (2001). Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology, 57, 1618-1628.
93. Redcay, E., & Courchesne, E. (2005). When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biological Psychiatry, 58, 1-9.
94. Redcay, E., & Courchesne, E. (2008). Deviant functional magnetic resonance imaging patterns of brain activity to speech in 2-3-year-old children with autism spectrum disorder. Biological Psychiatry, 64, 589-598.
95. Rippon, G., Brock, J., Brown, C., & Boucher, J. (2007). Disordered connectivity in the autistic brain: Challenges for the "new psychophysiology". International Journal of Psychophysiology, 63, 164-172.
96. Rosenberg, R.E., Law, J.K., Yenokyan, G., McGready, J., Kaufmann, W.E., & Law, P.A. (2009). Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Archives of Pediatrics and Adolescent Medicine, 163, 907-914.
97. Ross, B., & Bluml, S. (2001). Magnetic resonance spectroscopy of the human brain. The Anatomical Record, 265, 54-84.
98. Ross, B., & Michaelis, T. (1994). Clinical applications of magnetic resonance spectroscopy. Magnetic Resonance Quarterly, 10, 191-247.
99. Rubenstein, J.L.R., & Merzenich, M.M. (2003). Model of autism: Increased ratio of excitation/inhibition in key neural systems. Genes, Brain, and Behavior, 2, 255-267.
100. Rudkin, T.M., & Arnold, D.L. (1999). Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders. Archives of Neurology, 56, 919-926.
101. Samaco, R.C., Hogart, A., & LaSalle, J.M. (2005). Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Human Molecular Genetics, 14, 483-492.
102. Sansa, G., Carlson, C., Doyle, W., Weiner, H.L., Bluvstein, J., etal. (2011). Medically refractory epilepsy in autism. Epilepsia, 52, 1071-1075.
103. Satlin, A., Bodick, N., Offen, W.W., & Renshaw, P.F. (1997). Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: Changes after treatment with xanomeline, an M1 selective cholinergic agonist. The American Journal of Psychiatry, 154, 1459-1461.
104. Schultz, R.T., Gauthier, I., Klin, A., Fulbright, R.K., Anderson, A.W., etal. (2000). Abnormal ventral temporal cortical activity during face discrimination among individuals with autism and Asperger syndrome. Archives of General Psychiatry, 57, 331-340.
105. Schumann, C.M., Hamstra, J., Goodlin-Jones, B.L., Lotspeich, L.J., Kwon, H., etal. (2004). The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. The Journal of Neuroscience, 24, 6392-6401.
106. Serajee, F.J., Zhong, H., Nabi, R., & Huq, A.H. (2003). The metabotropic glutamate receptor 8 gene at 7q31: Partial duplication and possible association with autism. Journal of Medical Genetics, 40, e42.
107. Shinohe, A., Hashimoto, K., Nakamura, K., Tsujii, M., Iwata, Y., etal. (2006). Increased serum levels of glutamate in adult patients with autism. Progress in Neuro-psychopharmacology & Biological Psychiatry, 30, 1472-1477.
108. Shukla, D.K., Keehn, B., & Muller, R.A. (2011). Tract-specific analyses of diffusion tensor imaging show widespread white matter compromise in autism spectrum disorder. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 52, 286-295.
109. Soher, B.J., van Zijl, P.C., Duyn, J.H., & Barker, P.B. (1996). Quantitative proton MR spectroscopic imaging of the human brain. Magnetic Resonance in Medicine, 35, 356-363.
110. Sokhadze, E., Baruth, J., Tasman, A., Mansoor, M., Ramaswamy, R., etal. (2010). Low-frequency repetitive transcranial magnetic stimulation (rTMS) affects event-related potential measures of novelty processing in autism. Applied Psychophysiology and Biofeedback, 35, 147-161.
111. Sokol, D.K., Dunn, D.W., Edwards-Brown, M., & Feinberg, J. (2002). Hydrogen proton magnetic resonance spectroscopy in autism: Preliminary evidence of elevated choline/creatine ratio. Journal of Child Neurology, 17, 245-249.
112. Stanley, J.A. (2002). In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders. Canadian Journal of Psychiatry, 47, 315-326.
113. Tzika, A.A., Vajapeyam, S., & Barnes, P.D. (1997). Multivoxel proton MR spectroscopy and hemodynamic MR imaging of childhood brain tumors: Preliminary observations. AJNR. American Journal of Neuroradiology, 18, 203-218.
114. Vargas, D.L., Nascimbene, C., Krishnan, C., Zimmerman, A.W., & Pardo, C.A. (2005). Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology, 57, 67-81.
115. Watanabe, M., Maemura, K., Kanbara, K., Tamayama, T., & Hayasaki, H. (2002). GABA and GABA receptors in the central nervous system and other organs. International Review of Cytology, 213, 1-47.
116. Weng, S.J., Wiggins, J.L., Peltier, S.J., Carrasco, M., Risi, S., etal. (2010). Alterations of resting state functional connectivity in the default network in adolescents with autism spectrum disorders. Brain Research, 1313, 202-214.
117. Wing, L. (1997). The history of ideas on autism. Autism, 1, 13-23.
118. Yoo, H.J., Cho, I.H., Park, M., Yang, S.Y., & Kim, S.A. (2012). Family based association of GRIN2A and GRIN2B with Korean autism spectrum disorders. Neuroscience Letters, 512, 89-93.